OS Therapies Incorporated

OSTX · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$9-$8-$6-$7
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0$2$1$1
Other Non-Cash$1$3$2$2
Operating Cash Flow-$7-$3-$4-$4
Investing Activities
PP&E Inv.$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$2$3$4$3
Stock Issued$5$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$31$0$0$0
Other Fin. Act.$37-$0-$0$0
Financing Cash Flow$13$3$4$3
Forex Effect$0$0$0$0
Net Chg. in Cash$5-$0$0-$1
Supplemental Information
Beg. Cash$0$0$0$1
End Cash$6$0$0$0
Free Cash Flow-$7-$3-$4-$4
OS Therapies Incorporated (OSTX) Financial Statements & Key Stats | AlphaPilot